Stellios Trikounakis
Physician Assistant · Garnerville, NYNPI 1235341959
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,244, more than ten times the $55 reported in 2021. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$549
- Bayer$387
- Astellas Pharma US Inc$371
- Lilly USA, LLC$269
- Novartis$267
- Amgen$197
- plus $1K from 16 others
What the payments were for
- Speaking & faculty fees$251%
- Food & beverage$3,05198%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $549 |
| Bayer | 18 | $387 |
| Astellas Pharma US Inc | 12 | $371 |
| Lilly USA, LLC | 12 | $269 |
| Novartis | 12 | $267 |
| Amgen | 8 | $197 |
| Esperion Therapeutics, Inc. | 6 | $143 |
| Abbott | 4 | $143 |
| GSK | 7 | $131 |
| Boehringer Ingelheim | 4 | $99 |
| AstraZeneca | 6 | $98 |
| Ardelyx, Inc. | 4 | $95 |
| Pfizer | 5 | $90 |
| Shield Therapeutics Inc | 2 | $80 |
| Merck | 2 | $43 |
| Exact Sciences | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Lundbeck LLC | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| Dexcom, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$3,109 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KerendiaFinerenone | 522 | $411,179 |
| JardianceEmpagliflozin | 451 | $393,540 |
| OzempicSemaglutide | 278 | $266,804 |
| JanuviaSitagliptin Phosphate | 291 | $247,600 |
| JanumetSitagliptin Phos/Metformin Hcl | 193 | $157,971 |
| RybelsusSemaglutide | 100 | $136,884 |
| TrulicityDulaglutide | 119 | $130,807 |
| TradjentaLinagliptin | 160 | $127,400 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 151 | $106,854 |
| VascepaIcosapent Ethyl | 255 | $101,989 |
| EliquisApixaban | 144 | $93,697 |
| FarxigaDapagliflozin Propanediol | 100 | $87,594 |
| LinzessLinaclotide | 107 | $66,973 |
| Jentadueto XrLinagliptin/Metformin Hcl | 81 | $64,842 |
| ProliaDenosumab | 35 | $56,101 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Jentadueto Xr, Synjardy Xr, Synjardy | $99 | $665,163799 claims |
| MerckJanuvia, Janumet, Janumet Xr | $43 | $512,425635 claims |
| BayerKerendia | $387 | $411,179522 claims |
| Novo NordiskOzempic, Rybelsus | $549 | $403,688378 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $269 | $186,144164 claims |
| AstraZenecaFarxiga, Lokelma, Breztri Aerosphere, Brilinta | $98 | $136,847176 claims |
| PfizerEliquis | $90 | $93,697144 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $131 | $62,951123 claims |
| AmgenProlia | $197 | $56,10135 claims |
| NovartisEntresto | $267 | $22,26826 claims |
| Astellas Pharma US IncMyrbetriq | $371 | $13,94917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Garnerville
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.